Overview

Phase 1 Study to Assess AER-271

Status:
Completed
Trial end date:
2019-08-28
Target enrollment:
Participant gender:
Summary
The objective of this Phase 1 trial is to assess the safety, tolerability and pharmacokinetics of AER-271 in health subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Aeromics, Inc.
Collaborator:
Covance